This section presents pharmaceutical projects that are announced from time-to-time around the world.

QuVa Pharma Announces Pharma Facility Expansion

QuVa Pharma has announced expansion plans of its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey

Catalent Invests US$9million in a New Clinical Supply Facility in San Diego

Catalent has invested US$9million in a new clinical supply facility in San Diego The new 24,257 squarefeet facility is expected to provide clinical supply services to clients in the early stages of clinical development

Atlas Biotechnologies Announces Expansion Plan in Europe

Atlas Biotechnologies is pleased to announce its expansion into European markets starting with Denmark The expansion includes a new medical cannabis project Atlas Growers Denmark

Cambrex to Expand Its Edinburgh Screening Facility

Cambrex corporation announced plans to expand its facility in Edinburgh, Scotland, doubling the current footprint to 15,000 square feet

Pfizer Invests US$500 million For Gene Therapy Facility Expansion

Pfizer has announced its plans to invest US$500 million to construct a stateoftheart gene therapy manufacturing facility in Sanford, North Carolina

Fujifilm Irvine Plans New Manufacturing Facility in Europe

Fujifilm Irvine Scientific announced plans to build a new manufacturing facility to accelerate the development in bioproduction, and cell and gene therapy markets in Tilburg, Netherlands

Lonza Expands its Manufacturing Capabilities at Tampa Site

Lonza announced the completion of the expansion of US$15 million multiphase solid oral dose development and manufacturing capabilities at its Tampa, FL USA site

Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem

Mapi Pharma has signed a long term lease agreement at the HarHotzvim HiTech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products

Colorcon Plans to Build a New Starch Manufacturing Unit

Colorcon announced its plans to build a new starch manufacturing unit in Amsterdam, Netherlands This new facility is planned to double the existing manufacturing capacity for Starch 1500, Pregelatinised Maize Starch, supporting the continued growth of Colorcons excipient business across the world

Kite Announces Plans to Build a New Manufacturing Industry

Kite announces plans to build industryleading cell therapy manufacturing capabilities with a new viral vector facility in Oceanside, California

AirBridgeCargo - Air frieght solutions for your Pharma